About Zentalis Pharmaceuticals Inc
- Industry: Biotechnology
- Exchange: NASDAQ NMS - GLOBAL MARKET
- Country: US
- Website: https://www.zentalis.com/
Frequently Asked Questions
What is the 52-week range for ZNTL?
The 52-week high is $6.95 and the 52-week low is $1.212.
What is the P/E ratio for ZNTL?
The P/E ratio data is currently unavailable.
What is the dividend yield for ZNTL?
This company does not currently pay a dividend or the data is unavailable.
What is the Return on Equity (ROE)?
The trailing twelve months (TTM) Return on Equity is -52.77%.
What is the Net Profit Margin?
Net Margin data is currently unavailable.
What is the Price to Book (P/B) Ratio?
The annual Price to Book ratio stands at 0.45.
Analyst Recommendation Trends
Wall Street analyst consensus for ZNTL over the last few months:
Latest ZNTL News
This Small Biotech’s Cancer Drug Could Reach $1.3 Billion In Peak Sales
William Blair initiates Zentalis (ZNTL) at Outperform, citing a $1.3B peak sales potential for lead cancer drug azenosertib.
William Blair Initiates Coverage On Zentalis Pharmaceuticals with Outperform Rating
William Blair analyst Matt Phipps initiates coverage on Zentalis Pharmaceuticals (NASDAQ:ZNTL) with a Outperform rating.
Zentalis Pharmaceuticals, Inc. (ZNTL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
Zentalis Pharmaceuticals, Inc. (ZNTL) Morgan Stanley 24th Annual Global Healthcare Conference September 14, 2026 2:35 PM EDTCompany ParticipantsJulie...
Related Stocks (Peers)
Recent Insider Transactions
| Date | Name | Shares Changed | Price | Value |
|---|---|---|---|---|
| 2026-09-30 | Bruns Ingmar | +9,727 | $2.18 | $21,205 |
| 2026-08-14 | WALTERS GROUP | +4,335,000 | $3.5 | $15,172,500 |
| 2026-06-16 | Myers Scott Dunseth | +57,100 | - | - |
| 2026-05-26 | Campbell Shannon | +114,200 | - | - |
| 2026-02-10 | Vultaggio Vincent | -6,894 | $2.4223 | $16,699 |
| 2026-02-09 | Vultaggio Vincent | -3,379 | $2.3929 | $8,086 |
| 2026-02-09 | Bruns Ingmar | -335 | $2.3929 | $802 |
| 2026-02-09 | EASTLAND JULIA MARIE | -889 | $2.3929 | $2,127 |
| 2026-02-06 | Vultaggio Vincent | -29,951 | $2.4297 | $72,772 |
| 2026-02-06 | Bruns Ingmar | -2,962 | $2.4297 | $7,197 |
| 2026-02-06 | EASTLAND JULIA MARIE | -7,866 | $2.4297 | $19,112 |
| 2026-02-03 | Vultaggio Vincent | -556 | $2.515 | $1,398 |
| 2026-02-02 | Vultaggio Vincent | -2,540 | $2.55 | $6,477 |
| 2026-01-08 | EASTLAND JULIA MARIE | +775,000 | - | - |
| 2026-01-08 | Vultaggio Vincent | +100,000 | - | - |
| 2026-01-08 | Bruns Ingmar | +365,000 | - | - |
| 2026-01-08 | Bucher James B | +100,000 | - | - |
| 2025-12-31 | WALTERS GROUP | +6,459,973 | $1.2 | $7,751,968 |
| 2025-12-15 | Matrix Capital Management Company, LP | -7,500,000 | $1.33 | $9,975,000 |